Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Crisaborole 2% Top Oint
DRUG
3 trials
Sponsors
Massachusetts General Hospital
, University of California, Irvine
, Foundation University Islamabad
Conditions
Atopic Dermatitis
Atopic Dermatitis Eczema
Early Phase 1
Characterizing Skin Microbiome Change in Atopic Dermatitis
Completed
NCT04800185
University of California, Irvine
Atopic Dermatitis, Atopic Dermatitis Eczema
Start: 2021-03-23
End: 2022-04-30
Updated: 2024-02-02
Phase 4
Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis
NCT04214197
Massachusetts General Hospital
Atopic Dermatitis
Start: 2020-02-03
End: 2021-08-31
Target: 150
Updated: 2021-02-24
Unknown Phase
A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks
Not yet recruiting
NCT07519174
Foundation University Islamabad
Atopic Dermatitis
Start: 2026-06-01
End: 2027-01-01
Target: 72
Updated: 2026-04-09